MRK vs STE
By Alex · Tickerpine
Merck & Company, Inc. vs STERIS plc, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | STE |
|---|---|---|
| Price | $132.92 | $236.60 |
| Market cap | $327.94B | $23.07B |
| P/E ratio | 106.3 | 29.1 |
| ROE | 6.96% | 11.39% |
| Profit margin | 4.77% | 13.33% |
| Revenue growth | 5.10% | 7.30% |
| Dividend yield | 2.56% | 1.08% |
| Beta | 0.21 | 0.91 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs STE in plain English
- MRK is the bigger company — about 14.2× the market cap of STE.
- STE is cheaper on earnings (P/E 29.1 vs 106.3).
- STE earns a higher return on equity (11% vs 7%).
- STE is growing revenue faster (7% vs 5%).
- MRK has the higher dividend yield (2.56% vs 1.08%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
STE return calculator
See what $1,000 in STERIS plc would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.